Remarks from Anna Abram as prepared for delivery to the 2018 Intergovermental Meeting on Drug Compounding
Good morning and welcome. I am Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis here at the Food and Drug Administration. I would like to thank you all for traveling from near and far to be with us today to participate in our …